Document:

Exhibit 10.9 

 

LOAN
AGREEMENT AND PROMISSORY NOTE

 

	$1,400,000
(the “Principal Amount”)	September 27, 2021

  

FOR
VALUE RECEIVED, Michael Witherill, an individual with an address of 1206 E Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Maker”),
promises to pay to Rivulet Media, Inc., a Delaware corporation with an address of 1206 E Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Lender”),
the Principal Amount, or such greater or lesser amount thereof as may be outstanding from time to time, under the terms and provisions
as set forth below.

 

RECITALS

 

A.       Lender
is the owner of 29,076,665 shares of common stock and 2,907,666 shares of Series A Preferred Stock of Regen BioPharma, Inc. (the “Regen
Shares”).

 

B.       Lender
has sold or will sell the Regen Shares to Maker, and Maker, in turn, intends to sell the Regen Shares on the open market in one or more
at-the-market transactions.

 

C.       Lender
and Maker intend that, as full consideration for its purchase of the Regen Shares from Lender, Maker will pay to Lender the amount of
proceeds actually received by Maker resulting from Maker’s sale of the Regen Shares, the aggregate of which is expected to equal
or approximate the Principal Amount stated on this Loan Agreement and Promissory Note (this “Note”), but which may
be greater or less than such amount, and that the Principal Amount at any given time will be amended as needed to reflect the amount
of such proceeds received.

 

D.       Maker
is executing this Note to evidence his obligation to pay such amounts to Lender.

 

AGREEMENTS

 

1.       Interest.
No interest shall accrue under this Note.

 

2.       Payments.
Maker shall pay to Lender the amount of any proceeds received by Maker as a result of the sale by Maker of all or any portion of the
Regen Shares within two (2) Business Days (as defined below) of receipt of such proceeds. Maker may prepay all or any portion of this
Note at any time without penalty.

 

3.       Security.
This Note is secured by a first lien security interest on the Regen Shares held by Maker. Other than such security interest, this Note
is non-recourse.

 

4.       Default.
The existence or occurrence of any one or more of the following will constitute an “Event of Default” under this Note:

 

 4.1       Non-Performance.
Maker’s failure to comply timely and fully with any of the terms or provisions of this Note, including, without limitation, the
failure to pay all amounts due within ten (10) days after the due date.

 

 4.2       Bankruptcy;
Insolvency. Maker being insolvent by being unable to pay debts when due or by having liabilities in excess of assets; or Maker committing
an act of bankruptcy, making a general assignment for the benefit of creditors, or the filing by or against Maker of a voluntary or involuntary
petition in bankruptcy or for the appointment of a receiver (and any involuntary petition is not dismissed within thirty (30) days from
the filing thereof); or if there commences under any law relating to bankruptcy, insolvency, reorganization or relief of debtors, proceedings
affecting any significant part of Maker’s property or for the composition, extension, arrangement, or adjustment of any of its
obligations; or if a writ of attachment, execution, or any similar process is issued or levied against any significant part of Maker’s
property that is not released, stayed, bonded, or vacated within a reasonable time after its issue or levy.

     

     

    

5.       Return
of Regen Shares. If all or any portion of the Regen Shares remain unsold by Maker after November 30, 2021, then Maker shall promptly,
but in no less than seven (7) Business Days, transfer all of such shares back to Lender.

 

6.       Acceleration.
In addition to all other rights and remedies at law and/or equity Lender may have if an Event of Default occurs, Lender may, at its option
without further notice to Maker, declare immediately due and payable the unpaid principal balance of this Note together with all other
sums owed by Maker under this Note.

 

7.       Notices.
All notices that Company or Lender is required or permitted to give under this Note shall be delivered to the addresses of Company or
Lender set forth in the opening paragraph.

 

8.       Severability.
If any term or provision of this Note is, to any extent, determined by a court of competent jurisdiction to be invalid or unenforceable,
the remainder of this Note will not be affected, and the invalid or enforceable term or provision will be reduced or otherwise modified
by the court or authority only to the minimum extent necessary to make it valid and enforceable and to reflect the intent of the parties.
It is the intention of Company that, if any provision of this Note is capable of two constructions, one of which would render the provisions
void and the other of which would render the provisions valid, then the provision will have the meaning that renders it valid.

 

9.       Time
of the Essence. Time is of the essence of this Note. Whenever notice must be given, payment made, document delivered, or an act done
under this Note on a day that is not a Business Day, the notice may be given, payment made, document delivered, or act done on the next
following day that is a Business Day. “Business Day” means a day other than a Saturday, Sunday, or a day observed
as a legal holiday by the United States government or the State of Arizona.

 

10.       Governing
Law; Jurisdiction and Venue. This Note is to be governed by and interpreted in accordance with the laws of the State of Arizona.
Any legal action or proceeding with respect to this Note or any document related hereto shall be brought in Maricopa County, Arizona
in any court of competent jurisdiction, and, by execution and delivery of this Note, Company and Lender hereby accept the jurisdiction
and venue of such courts.

 

11.       Successors
and Assigns. This Note shall be binding upon and inure to the benefit of Maker and Lender and their respective successors and permitted
assigns. Maker may not voluntarily or involuntarily transfer, convey, or assign this Note, or any of its duties or obligations hereunder,
without Lender’s prior written consent, which may be withheld for any reason, or for no reason at all. As used herein, the term
“Lender” means and includes the successors and permitted assigns of Lender.

 

12.       Attorneys’
Fees and Costs. Each party shall bear its own expenses in connection with the issuance of this Note; provided, however, that if any
action at law or in equity is necessary to enforce or interpret the terms of this Note, the prevailing party shall be entitled to its
reasonable attorneys’ fees, costs, and disbursements in addition to any other relief to which such party may be entitled.

    2

     

    

13.       No
Waiver by Lender. No delay or failure of Lender in exercising any right hereunder shall affect such right, nor shall any single or
partial exercise of any right preclude further exercise thereof.

 

14.       Further
Assurances. Maker agrees to execute and deliver such further documents and to do such other acts and things as Lender may reasonably
request in order further to effect the purposes of this Note, the security interest in the Regen Shares, and the due performance by Maker
of his obligations hereunder.

 

	 	MAKER
	 	 	 
	 	/s/
    Michael Witherill
	 	Michael
    Witherill
	 	 	 
	 	LENDER
	 	Rivulet
    Media, Inc.,
	 	a
    Delaware corporation
	 	 	 
	 	By:	/s/
    Aaron Klusman
	 	 	Aaron
    Klusman, CEO

    3Exhibit 10.10

 

STOCK
SALE AGREEMENT

 

This
Stock Sale Agreement (this “Agreement”) is dated November 9, 2021 (the “Effective Date”), between Rivulet
Media, Inc., a Delaware corporation with an address of 1206 E Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Seller”),
and Damian Larson, an individual with an address of 6611 E. Mayo Blvd. #2059, Phoenix, AZ 85054 (“Purchaser”). The parties
hereby agree as follows:

 

RECITALS

 

A.       Seller
is the owner of 29,076,665 shares of common stock (the “Regen Shares”) of Regen BioPharma, Inc. (“Regen BioPharma”).

 

B.       Seller
desires to sell and transfer, and Purchaser desires to purchase, the Regen Shares on the terms and conditions set forth herein.

 

NOW
THEREFORE, in consideration of promises, mutual covenants, and undertakings herein and other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the parties hereby agree as follows:

 

AGREEMENTS

 

1.            
Sale and Assignment of Regen Shares; Resale of Shares.

 

(a)             
Subject to the terms of this Agreement, effective as of the Effective Date, Seller hereby sells, assigns, and transfers to Purchaser,
and Purchaser agrees to purchase from Seller, the Regen Shares, free and clear of all encumbrances. 

 

(b)            
Promptly following receipt of the Regen Shares pursuant to Section 1(a), Purchaser shall transfer the Regen Shares to a brokerage account
controlled by him, and agrees to use his best efforts to effect a subsequent sale of the Regen Shares in one or more open market transactions.

 

2.            
Purchase Price. 

 

(a)             
As consideration for the purchase of the Regen Shares, Purchaser shall pay to Seller the aggregate amount of proceeds actually received
by Purchaser resulting from Purchaser’s subsequent sale of the Regen Shares on the open market in one or more at-the-market transactions,
which amount, if sold as of November 5, 2021, would be expected to equal approximately $793,000, less (i) the fee described in Section
2(b) below, and (ii) the amount of any wire transfer fees incurred by Purchaser in connection with the transfer of such proceeds to Seller.
The parties will execute a Loan Agreement and Promissory Note to evidence the obligation to make the payments set forth herein. 

 

(b)            
As consideration for his best efforts to effect a subsequent sale of the Regen Shares, Purchaser will be entitled to retain 20% of the
first $50,000 of realized gross sale price for Regen Shares, for a total fee of up to $10,000 (but for clarity, if less than $50,000
is realized before this Agreement is terminated, then the fee shall be 20% of such lesser realized amount). If all or any portion of
the Regen Shares remain unsold by Purchaser after the date that is 60 days of the Effective Date, then the parties will negotiate in
good faith an additional fee or other arrangement with respect to the remaining Regen Shares, or, at Seller’s request, Purchaser
shall promptly (but in no less than 7 business days) transfer all such shares back to Seller and this Agreement shall be terminated.
Additionally, Purchaser may, in his sole discretion, transfer all remaining Regen Shares back to Seller, and provided that all amounts
due by Purchaser to Seller under this Agreement have been paid, this Agreement shall be terminated.

     

     

    

3.            
Taxes. Seller agrees to pay all taxes associated with the sale of the Regen Shares, whether incurred by Seller or by Purchaser
as a result of Purchaser’s subsequent sale of the Regen Shares on the open market.

 

4.            
Representations and Warranties of Seller. Seller represents and warrants to Purchaser that: (a) the Regen Shares have not been
assigned, sold, mortgaged, or pledged to any other person or entity, and Seller has all right, title, and interest in and to the Regen
Shares free and clear of all liens, charges, mortgages or security interests; (b) no person or entity whatsoever has any claim, right,
title, interest, or lien in, to, or on the Regen Shares; (c) Seller has full authority to sell, assign, and transfer the Regen Shares;
and (d) Seller acknowledges that Purchaser’s efforts to sell the Regen Shares will be conducted on a best-efforts basis only, and
that Purchaser makes no guaranty as the number, if any, of Regen Shares that will be sold or the sale price for such Regen Shares.

 

5.            
Representations and Warranties of Purchaser. Purchaser represents and warrants to Seller that: (a) Purchaser has had an opportunity
to conduct due diligence regarding the value of the Regen Shares and the operations and financial condition of Regen BioPharma as deemed
appropriate by Purchaser to satisfy himself of the condition of the Regen BioPharma and is relying upon his review and investigation
thereof and not upon any representation or statement of the Seller or any other person, firm, or corporation; (b) Purchaser has full
authority to enter into this Agreement and acquire the Regen Shares, and (c) Purchaser will use his best efforts to sell all of the Regen
Shares in one or more open market transactions.

 

6.            
Attorneys’ Fees. In the event of any action or proceeding to compel compliance with, or for a breach of, any of the terms
and conditions of this Agreement, the substantially prevailing party shall be entitled to recover from the non-prevailing party the costs
of such action or proceedings, including, without limitation, reasonable attorneys’ fees, costs and disbursements.

 

7.            
Additional Instruments. Each party, promptly upon the request of any other party, shall sign and have acknowledged and delivered
to the other party as may be appropriate, any and all additional instruments and assurances reasonably requested or appropriate to evidence
or give effect to the provisions of this Agreement.

 

8.            
General Provisions. 

 

(a)   
This Agreement shall be governed by and construed in accordance with the laws of the State of Arizona.

 

(b)  
This Agreement sets forth the complete and entire understanding of the parties hereto, and supersedes any prior agreement, with respect
to the subject matter hereof and may not be modified, amended, or otherwise altered except in writing executed by the parties.

 

(c)   
This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall
constitute one and the same instrument.

 

(d)  
Seller and Purchaser will each indemnify, defend, and hold harmless the other party against any losses incurred by such party that arise
as a result of the indemnifying party’s negligence, willful misconduct, or breach of this Agreement.

 

(Signature
Page Follows)

    2

     

    

IN
WITNESS WHEREOF, the undersigned have executed this Stock Sale Agreement as of the date set forth above.

 

	 	PURCHASER
	 	 	 
	 	/s/
    Damian Larson
	 	Damian
    Larson
	 	 	 
	 	SELLER
	 	Rivulet
    Media, Inc.,
	 	a
    Delaware corporation
	 	 	 
	 	By:
    	/s/
    Michael Witherill
	 	 	Michael
    Witherill, President

    3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]